Intermittent leukapheresis: an adjunct to low-dose chemotherapy for Sézary syndrome
McEvoy MT, Zelickson BD, Pineda AA, Winkelmann RK.
Eleven patients with S?©zary syndrome were treated with intermittent leukapheresis in addition to low-dose chlorambucil and prednisone. The results were as good as or better than those with chemotherapy alone. We believe the combined program with continuous leukapheresis to be optimal therapy but note that intermittent treatment offers some benefit for patients.